Dr. Javier S. Burgos new Managing Director of ibs.GRANADA and FIBAO
Since yesterday, August 3, 2017, the ibs.GRANADA and FIBAO have a new managing director, Dr. Javier S. Burgos, who is Ph.D. in Molecular Biology in the year 2000 by the Autonomous University of Madrid through the completion of the Doctoral Thesis in the area of drug search for neurodegenerative diseases, and which was carried out at the "Severo Ochoa" Molecular Biology Center. Degree in biological sciences by the University of Valencia (Biochemistry specialty) in 1994 and Bachelor of Degree by the same university in 1996 after defending the Bachelor's Thesis on the implication of herpes infection in head and neck cancer, a work that was carried out at the La Fe University Hospital in Valencia.
It was Postdoctoral Researcher y Teaching and Research Staff at the Autonomous University of Madrid until 2006, when he was appointed Scientific Director of the biopharmaceutical company Neuron Bio, a company listed on the Alternative Stock Market and in charge of seeking therapeutic and diagnostic solutions for Alzheimer's disease. In 2014 he was appointed Chief Executive Officer of this business.
Been Guest Researcher at the Children's Hospital of Los Angeles of the Keck School of Medicine of the University of Southern California (USA), at the Institute of Basic Health Sciences of the Federal University of Rio Grande do Sul (Brazil), and at the Bellvitge University Hospital in Barcelona (Spain).
He has been a teacher and professor of different master's degrees at the Autonomous University of Madrid, the CEU San Pablo University, the University of Granada, the Jaime I University of Castellón and the Polytechnic University of Valencia.
He is the author of more than 40 scientific articles in international journals, several book chapters, and participant as an inventor in ten patents in the field of diagnosis and treatment of Alzheimer's disease. He has participated as a researcher in 27 research projects in the field of biomedicine.
It has B, C and D1 approvals for the use of experimental animals according to Royal Decree 1201/2005.
In addition, he has supervised three doctoral theses in the field of the etiology of Alzheimer's disease (one of them received the Extraordinary Doctorate Award), and is a member of the editorial committee of the journals Journal of Alzheimer's Disease, American Journal of Neurodegenerative Disease y Journal of Viruses.
Additionally, he has taken various training courses on "Advanced Marketing Techniques", "Science and Technology Management", "Professional Strategy", "Patents and Utility Models", "Management of Improvement Processes", "Scientific Journalism" , “Translational Research”, and “Emotional Intelligence”, among others.